StockData
ENDRA Life Sciences Inc. logo

ENDRA Life Sciences Inc. (NDRA) income statement

NDRANasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$4.04+0.12 (+2.93%)

Close on Nov 18, 2026Market cap $6.05MP/E –Yield –

ENDRA Life Sciences Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
-291.6%

Financial strength

Current ratio
7.10
Debt to equity
–
Debt to assets
–
Cash to current liabilities
221.2%

Valuation

P/E ratio
–
Price to sales
–
Price to book
0.96
Dividend yield
–

See a number that looks wrong?